Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2024 Apr 12:rs.3.rs-4213303.
doi: 10.21203/rs.3.rs-4213303/v1.

Folate-conjugated organic CO prodrugs: Synthesis and CO release kinetic studies

Affiliations

Folate-conjugated organic CO prodrugs: Synthesis and CO release kinetic studies

Shameer M Kondengadan et al. Res Sq. .

Abstract

Carbon monoxide (CO) is an endogenous produced molecule and has shown efficacy in animal models of inflammation, organ injury, colitis and cancer metastasis. Because of its gaseous nature, there is a need for developing efficient CO delivery approaches, especially those capable of targeted delivery. In this study, we aim to take advantage of a previously reported approach of enrichment-triggered prodrug activation to achieve targeted delivery by targeting the folate receptor. The general idea is to exploit folate receptor-mediated enrichment as a way to accelerate a biomolecular Diels-Alder reaction for prodrug activation. In doing so, we first need to find ways to tune the reaction kinetics in order to ensure minimal rection without enrichment and optimal activation upon enrichment. In this feasibility study, we synthesized two diene-dienophile pairs and studied their reaction kinetics and ability to target the folate receptor. We found that folate conjugation significantly affects the reaction kinetics of the original diene-dienophile pairs. Such information will be very useful in future designs of similar targeted approaches of CO delivery.

Keywords: Carbon Monoxide; Diels-Alder reaction; Enrichment triggered delivery; Folate conjugate; Reaction kinetics.

PubMed Disclaimer

Conflict of interest statement

Authors declare no competing interests related to the work submitted in this publication.

Figures

Figure 1
Figure 1
Design of organic CO prodrugs.[53]
Figure 2
Figure 2
Enrichment triggered delivery of CO by folate (A), and TPP (B) conjugates. C) Structures of folate and TPP conjugates used in Fig. A-B (“Created with BioRender.com”)
Figure 3
Figure 3
CO release kinetic studies of folate-conjugated prodrug partners (19a/19b, 11), and control compounds (20, 21) by using turn-on fluorescence of the product.
Figure 4
Figure 4
Determination of the pseudo-first order and second order rate constants for the Diels-Alder reactions. A-C) cycloalkyne (21) and cyclopentadienone (20); E-G cycloalkyne (11) and cyclopentadienone (19b). Fluorescent intensity was monitored by incubating different concentrations of cyclopentadienone and a fixed concentration of cycloalkyne (50 μM) with excitation and emission wavelength of 375 and 465 nm respectively. D, H) Second-order rate constant between cycloalkyne and cyclopentadienone.

References

    1. Shoshan MC, Linder S. Target specificity and off-target effects as determinants of cancer drug efficacy. Expert Opin Drug Metab Toxicol. 2008;4(3):273–80. doi:10.1517/17425255.4.3.273. - DOI - PubMed
    1. Sahoo S, Kariya T, Ishikawa K. Targeted delivery of therapeutic agents to the heart. Nat Rev Cardiol. 2021;18(6):389–99. doi:10.1038/s41569-020-00499-9. - DOI - PMC - PubMed
    1. Khongorzul P, Ling CJ, Khan FU, Ihsan AU, Zhang J. Antibody-Drug Conjugates: A Comprehensive Review. Mol Cancer Res. 2020;18(1):3–19. doi:10.1158/1541-7786.Mcr-19-0582. - DOI - PubMed
    1. Perez HL, Cardarelli PM, Deshpande S, Gangwar S, Schroeder GM, Vite GD et al. Antibody-drug conjugates: current status and future directions. Drug Discov Today. 2014;19(7):869–81. doi:10.1016/j.drudis.2013.11.004. - DOI - PubMed
    1. Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153(3):198–205. doi:10.1016/j.jconrel.2011.06.001. - DOI - PMC - PubMed

Publication types

LinkOut - more resources